SEARCH RESULTS for GLAXOSMITHKLINE BIOLOGICALS SA

Recent Patent Assignments Patent Assignments - (Total found: 80)

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
30-Sep-2016

(X0) 14764997: INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

(A1) 20150366796: INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/565

30-Sep-2016

(X0) 14652234: CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

(A1) 20150320852: CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/620

30-Sep-2016

(X0) 14775760: RNA PURIFICATION METHODS

(A1) 20160024139: RNA PURIFICATION METHODS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/668

30-Sep-2016

(X0) 14786641: MUTANT BACTERIA FOR PRODUCTION OF GENERALIZED MODULES FOR MRMBRANE ANTIGENS

(A1) 20160067326: MUTANT BACTERIA FOR PRODUCTION OF GENERALIZED MODULES FOR MRMBRANE ANTIGENS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/712

30-Sep-2016

(X0) 14435258: NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

(A1) 20150273036: NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39894/145

08-Aug-2016

9156894: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

8398999: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

8226960: CHIMERIC, HYBRID AND TANDEM POLYPEPTIDES OF MENINGOCOCCAL NMB1870

NOVARTIS AG

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39348/942

05-Aug-2016

(X0) 14989737: DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES

(A1) 20160199476: DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39336/946

03-Aug-2016

8637044: Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes.

8168194: FUSION PROTEINS COMPRISING CD4 MINIMAL MODULES AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) TAT SCAFFOLD POLYPEPTIDES THAT ARE CAPABLE OF BINDING TO THE HIV ENVELOPE AND EXPOSING CRYPTIC NEUTRALIZATION EPITOPES.

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39315/838

01-Aug-2016

(X0) 14918417: MULTIPLE VARIANTS OF MENINGOCOCCAL PROTEIN NMB1870

(A1) 20160039887: MULTIPLE VARIANTS OF MENINGOCOCCAL PROTEIN NMB1870

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39292/434

20-Jun-2016

(X0) 14961772: COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

(A1) 20160158335: COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38945/527

15-Jun-2016

8158418: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

7572453: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

7531180: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

9255126: CHIMERIC ALPHAVIRUS REPLICON PARTICLES

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/296

15-Jun-2016

8753651: Capsular polysaccharide solubilisation and combination vaccines

9358278: CAPSULAR POLYSACCHARIDE SOLUBILISATION AND COMBINATION VACCINES

8889152: Capsular Polysaccharides Solubilisation and Combination Vaccines

8852606: CAPSULAR POLYSACCHARIDE SOLUBILISATION AND COMBINATION VACCINES

NOVARTIS AG

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/319

15-Jun-2016

(X0) 10858858: Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

(A1) 20050118275: Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

(B2) 9107831: Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/339

15-Jun-2016

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38903/378

15-Jun-2016

(X0) 13982042: ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

(A1) 20140017279: ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38903/385

15-Jun-2016

(X0) 14381513: IMMUNOLOGICALLY USEFUL ARGININE SALTS

(A1) 20150125475: IMMUNOLOGICALLY USEFUL ARGININE SALTS

(B2) 9320748: IMMUNOLOGICALLY USEFUL ARGININE SALTS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38903/441

15-Jun-2016

(X0) 14424370: IMMUNOGENIC COMPOSITION

(A1) 20150224204: IMMUNOGENIC COMPOSITION

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38903/464

10-Jun-2016

(X0) 12816534: High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal Assays

(A1) 20110312510: High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal Assays

(B2) 9365885: High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal Assays

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38865/714

08-Jun-2016

(X0) 10543455: Injectable vaccines against multiple meningococcal serogroups

(A1) 20070082014: Injectable vaccines against multiple meningococcal serogroups

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38829/172

08-Jun-2016

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38829/509

08-Jun-2016

(X0) 14357270: IMMUNOGENIC COMPLEXES OF POLYANIONIC CARBOMERS AND ENV POLYPEPTIDES AND METHODS OF MANUFACTURE AND USE THEREOF

(A1) 20140314703: IMMUNOGENIC COMPLEXES OF POLYANIONIC CARBOMERS AND ENV POLYPEPTIDES AND METHODS OF MANUFACTURE AND USE THEREOF

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38829/764

08-Jun-2016

(X0) 13790948: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

(A1) 20130236492: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

(B2) 9375471: ADJUVANTED FORMULATIONS OF BOOSTER VACCINES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38829/915

02-Jun-2016

(X0) 15015041: COMBINATION NEISSERIAL COMPOSITIONS

(A1) 20160151476: COMBINATION NEISSERIAL COMPOSITIONS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38595/473

01-Jun-2016

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38754/706

14-Mar-2016

(X0) 14363387: CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

(A1) 20150132333: CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37951/417

14-Mar-2016

(X0) 14425037: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

(A1) 20150315248: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37951/441

04-Mar-2016

(X0) 14363387: CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

(A1) 20150132333: CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37880/900

24-Feb-2016

(X0) 13997017: PROCESSES FOR PURIFYING C. DIFFICILE PS-II SACCHARIDE WITH ACID AND EMZYME TREATMENTS

(A1) 20130315959: PROCESSES FOR PURIFYING C. DIFFICILE PS-II SACCHARIDE WITH ACID AND EMZYME TREATMENTS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37792/850

24-Feb-2016

(X0) 14425037: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

(A1) 20150315248: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37792/925

24-Feb-2016

(X0) 11666786: IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS

(A1) 20100015212: IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS

(B2) 9206399: IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

37800/287